The probability of achieving final corticosteroid discontinuation, complete clinical response and remission at specific time points after treatment initiation by Weibull distribution for 307 patients with JDM
| Time point, months . | Total number of patients available, n (%) . | Final corticosteroid discontinuation, % . | Complete clinical response, % . | Remission, % . |
|---|---|---|---|---|
| 12 | 278 (90.6) | 9.6 | 7.0 | 3.3 |
| 24 | 222 (72.3) | 21.9 | 15.1 | 8.9 |
| 36 | 177 (57.6) | 34.2 | 23.1 | 15.6 |
| 48 | 135 (44.0) | 45.6 | 30.6 | 22.8 |
| 60 | 105 (34.2) | 55.6 | 37.7 | 30.2 |
| Time point, months . | Total number of patients available, n (%) . | Final corticosteroid discontinuation, % . | Complete clinical response, % . | Remission, % . |
|---|---|---|---|---|
| 12 | 278 (90.6) | 9.6 | 7.0 | 3.3 |
| 24 | 222 (72.3) | 21.9 | 15.1 | 8.9 |
| 36 | 177 (57.6) | 34.2 | 23.1 | 15.6 |
| 48 | 135 (44.0) | 45.6 | 30.6 | 22.8 |
| 60 | 105 (34.2) | 55.6 | 37.7 | 30.2 |
Data are reported out to 60 months, due to large number of patients lost to follow-up after that time.
The probability of achieving final corticosteroid discontinuation, complete clinical response and remission at specific time points after treatment initiation by Weibull distribution for 307 patients with JDM
| Time point, months . | Total number of patients available, n (%) . | Final corticosteroid discontinuation, % . | Complete clinical response, % . | Remission, % . |
|---|---|---|---|---|
| 12 | 278 (90.6) | 9.6 | 7.0 | 3.3 |
| 24 | 222 (72.3) | 21.9 | 15.1 | 8.9 |
| 36 | 177 (57.6) | 34.2 | 23.1 | 15.6 |
| 48 | 135 (44.0) | 45.6 | 30.6 | 22.8 |
| 60 | 105 (34.2) | 55.6 | 37.7 | 30.2 |
| Time point, months . | Total number of patients available, n (%) . | Final corticosteroid discontinuation, % . | Complete clinical response, % . | Remission, % . |
|---|---|---|---|---|
| 12 | 278 (90.6) | 9.6 | 7.0 | 3.3 |
| 24 | 222 (72.3) | 21.9 | 15.1 | 8.9 |
| 36 | 177 (57.6) | 34.2 | 23.1 | 15.6 |
| 48 | 135 (44.0) | 45.6 | 30.6 | 22.8 |
| 60 | 105 (34.2) | 55.6 | 37.7 | 30.2 |
Data are reported out to 60 months, due to large number of patients lost to follow-up after that time.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
